RxDoctor Payments Data

Philip Myers, DO

Orthopaedic Surgery · Gulfport, MSNPI 1003254525

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (53.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Arthrex at 57.5% of the total. Reporting peaked in 2021 at $25,661 and has fallen 99.0% since, to $267 in 2025.

$42,561in general payments, 2019–2025

Across 104 payments — averaging $409.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$24K
  • Advanced Orthopaedic Solutions, Inc.$12K
  • Stryker$2K
  • Amgen$821
  • ALON Medical Technology$617
  • DJO, LLC$359
  • plus $2K from 23 others

What the payments were for

  • Consulting fees$22,70053%
  • Speaking & faculty fees$11,70027%
  • Travel & lodging$3,1747%
  • Food & beverage$3,7889%
  • Education$1,2003%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$42,561 in reported general payments places this provider in the 85th percentile of 170 orthopaedic surgery providers in Mississippi.

See all orthopaedic surgery providers in Mississippi

Medicare billing

Part B allowed, 2024
$125,164
Medicare patients
221
Services billed
909

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib22$334
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen45$301
Tizanidine Hcl12$188
Ondansetron Hcl30$149
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$129
Hydroxyzine Pamoate11$101
Meloxicam14$41

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Gulfport

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →